ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
139.64
-0.90 (-0.64%)
At close: Apr 15, 2025, 4:00 PM
143.99
+4.35 (3.12%)
Pre-market: Apr 16, 2025, 4:53 AM EDT
ICU Medical Market Cap
ICU Medical has a market cap or net worth of $3.42 billion as of April 15, 2025. Its market cap has increased by 32.14% in one year.
Market Cap
3.42B
Enterprise Value
4.75B
1-Year Change
32.14%
Ranking
Category
Stock Price
$139.64
Market Cap Chart
Since December 1, 1998, ICU Medical's market cap has increased from $148.00M to $3.42B, an increase of 2,213.40%. That is a compound annual growth rate of 12.64%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 14, 2025 | 3.45B | -9.30% |
Dec 31, 2024 | 3.80B | 57.79% |
Dec 29, 2023 | 2.41B | -36.25% |
Dec 30, 2022 | 3.78B | -25.08% |
Dec 31, 2021 | 5.04B | 12.02% |
Dec 31, 2020 | 4.50B | 16.33% |
Dec 31, 2019 | 3.87B | -17.78% |
Dec 31, 2018 | 4.70B | 8.20% |
Dec 29, 2017 | 4.35B | 80.70% |
Dec 30, 2016 | 2.41B | 33.55% |
Dec 31, 2015 | 1.80B | 43.18% |
Dec 31, 2014 | 1.26B | 34.06% |
Dec 31, 2013 | 938.70M | 5.63% |
Dec 31, 2012 | 888.70M | 42.79% |
Dec 30, 2011 | 622.40M | 25.46% |
Dec 31, 2010 | 496.10M | -8.06% |
Dec 31, 2009 | 539.60M | 13.34% |
Dec 31, 2008 | 476.10M | -4.76% |
Dec 31, 2007 | 499.90M | -16.26% |
Dec 29, 2006 | 597.00M | 9.72% |
Dec 30, 2005 | 544.10M | 46.66% |
Dec 31, 2004 | 371.00M | -20.74% |
Dec 31, 2003 | 468.10M | -11.28% |
Dec 31, 2002 | 527.60M | 36.86% |
Dec 31, 2001 | 385.50M | 52.55% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 677.40B |
UnitedHealth Group | 536.99B |
Johnson & Johnson | 371.98B |
AbbVie | 316.82B |
Novo Nordisk | 294.67B |
Abbott Laboratories | 221.92B |
AstraZeneca | 210.97B |
Novartis AG | 206.74B |